A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors

NCT05773937 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: 9MW2821

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.